Medical researchers reviewing clinical data in a laboratory

Research & Pipeline

Clinical Trials and Collaborations

Learn how Helio is advancing cancer research through clinical studies and collaborations with leading partners.

Collaboration Network

Our Partners in Health

We are proud to collaborate with organisations that share our mission and values. Today, we partner with leading medical institutions and research centres to advance early cancer detection.

Helio Genomics

Academic Research

Cancer Centers

Clinical Networks

Healthcare Systems

Research Institutions

Clinical Research Pipeline

Our Current Studies

We are dedicated to making accurate early detection available for more cancers. Helio is engaged in multiple prospective, multi-centre studies across the United States.

ENCORE

Completed

A study defining the performance of the HelioLiver test in people diagnosed with liver cancer across stages I to IV.

NCT05059665 View Study

CLiMB

Completed

A multi-centre, prospective US study comparing the sensitivity and specificity of the HelioLiver test against ultrasound, in people at high risk of HCC due to cirrhosis.

NCT03694600 View Study

FAST

Ongoing

A prospective R01 study sponsored by the NCI, with Mount Sinai and other US institutions, evaluating novel screening methods and biomarkers.

NCT04539717 View Study

ELITE

Ongoing

A multi-centre, prospective US study discovering new biomarkers across cancer types, including colon, lung, and breast.

NCT05181826 View Study

LIVER-1

Ongoing

A multi-centre, prospective US study developing and validating Helio's blood test in people at high risk of HCC, and in those already HCC-positive.

NCT05199259 View Study

Researchers in a clinical collaboration meeting

Partner With Us

Let's Advance Cancer Research Together

Helio is looking to partner with research and clinical organisations that care for people who have cancer or are at high risk of developing it. Leave us a message if you'd like to collaborate on upcoming clinical trials and research.